Who invested in Grow Therapy?
Grow Therapy's investors include TCV, Growth Equity at Goldman Sachs Alternatives, Sequoia Capital, Goldman Sachs and Menlo Ventures, and 4 more on record. TCV led its latest round.

United States · Series D startup
One round we have observed, with the 9 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Raised 8 months agoValuation: $3.0B, Mar 2026
Follow Grow Therapy and see its new rounds in your feed. Start following
Funding summaryUpdated 5 Nov 2026
$150Mraised across 1 round since 2026, from 2 sources
Reported by AlleyWatch and 1 other
Grow Therapy's investors include TCV, Growth Equity at Goldman Sachs Alternatives, Sequoia Capital, Goldman Sachs and Menlo Ventures, and 4 more on record. TCV led its latest round.
Grow Therapy has raised $150M across 1 round since 2026.
Grow Therapy's most recent round was a Series D of $150M in Mar 2026, led by TCV.
Its most recent round, $150M in Mar 2026, is also its largest on record.
Grow Therapy's first round on record, in Mar 2026, was backed by TCV, Growth Equity at Goldman Sachs Alternatives and Sequoia Capital and 6 others.
Grow Therapy's latest named round is a Series D, in Mar 2026.
Grow Therapy is based in the United States.
TCV led the Series D in 2026.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.